[{"indications": "Indications\u00a0leprosy, dermatitis\r\nherpetiformis; Pneumocystis jirovecii (Pneumocystis carinii) pneumonia (section 5.4.8)", "name": "DAPSONE", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "5 Infections", "5.1 Antibacterial drugs", "5.1.10 Antileprotic drugs", "DAPSONE"], "cautions": "Cautions\u00a0cardiac or pulmonary\r\ndisease; anaemia (treat severe anaemia before starting); susceptibility to haemolysis including G6PD deficiency (section 9.1.5); avoid in acute porphyria (section 9.8.2); interactions: Appendix 1\r\n(dapsone)Blood disorders\u00a0On long-term treatment,\r\npatients and their carers should be told how to recognise signs of\r\nblood disorders and advised to seek immediate medical attention if\r\nsymptoms such as fever, sore throat, rash, mouth ulcers, purpura,\r\nbruising or bleeding develop", "side-effects": "Side-effects\u00a0(dose-related and uncommon at doses used for leprosy),\r\nhaemolysis, methaemoglobinaemia, neuropathy, allergic dermatitis (rarely\r\nincluding toxic epidermal necrolysis and Stevens-Johnson syndrome),\r\nanorexia, nausea, vomiting, tachycardia, headache, insomnia, psychosis,\r\nhepatitis, agranulocytosis; dapsone syndrome (rash\r\nwith fever and eosinophilia)\u2014discontinue immediately (may progress\r\nto exfoliative dermatitis, hepatitis, hypoalbuminaemia, psychosis\r\nand death)", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/3927.htm", "doses": ["Leprosy, 1\u20132\u00a0mg/kg daily, see notes above", "Dermatitis herpetiformis, see specialist literature"], "pregnancy": "Pregnancy\u00a0folic acid 5\u00a0mg daily should be given to mother throughout\r\npregnancy; neonatal haemolysis and methaemoglobinaemia reported in\r\nthird trimester"}]